title: Cost-benefit evaluation of a preventive intervention on the biological risk in health: the accidental puncture during the administration of insulin in the University Hospital "Federico II" of Naples.
abstract: BACKGROUND
  The occupational exposure to biological risk is a frequent event that affects millions of workers in the health sector. Operators are exposed to accidental contact with blood and other potentially infectious biological materials with a frequency higher than that observed in the population (occupational exposure). The pathogens most frequently implicated are the human immunodeficiency virus (HIV), hepatitis C (HCV) and hepatitis B (HBV) viruses. The World Health Organization estimates that each year more than 3 million health workers hurt themselves with an object/edge definitely contaminated with at least one HIV (about 170,000 exposures), hepatitis B (approximately 2,000,000 exposures) and hepatitis C (approximately 900,000 exposures). In Italy approximately 100,000 percutaneous exposures/year are estimated to take place. The needlestick injuries in health care workers are, in large part, preventable by adopting measures such as the use of instrumental needlesticks Prevention Devices - NPDs. The adoption of the NPDs is extremely effective in reducing occupational exposure to biological risk (from 63 % to 100 % reduction).
  
  
  METHODS
  The aim of this study was to evaluate whether the adoption of NPDs for insulin therapy is costeffective in terms of prevention of accidents by Biohazard, compared to administration of insulin with traditional methods (syringe + vial). The estimation is carried out both in the light of current legislation (European Directive 2010/32 and 81/08 Italian Law) and epidemiological data and cost of accidents (according to frequency) and alternative interventions.
  
  
  RESULTS
  The evaluation of cost-effectiveness included the construction of an economic model that would allow the weighting of the costs of accidents that can occur following the administration of insulin therapy with traditional methods. The economic model was developed taking into account the international literature on the phenomenon of "accidental puncture" and allowed the financial quantification of the event. Then we calculated the cost of insulin therapy using the traditional methodology and the cost has been converted to the cost of insulin therapy when administered by NPDs. The period of the study was the year 2010.
  
  
  CONCLUSIONS
  The data thus obtained were used to evaluate the benefits of implementing NPDs for insulin therapy, in terms not only of economic advantage but also of preventive efficacy and on the cost of the accident.
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Montella
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Schiavone
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Apicella
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Di Silverio
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Gaudiosi
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Ambrosone
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Moscaritolo
authors.affiliation: Department of Public Health, University of Naples "Federico II", Naples, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Triassi
mesh_terms: D000062:Accidents, Occupational / Q000191:economics / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D004867:Equipment Design; D015658:HIV Infections / Q000191:economics / Q000517:prevention & control; D006282:Health Personnel; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control; D006526:Hepatitis C / Q000191:economics / Q000517:prevention & control; D006785:Hospitals, University / Q000191:economics; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000191:economics; D018803:Models, Economic; D016602:Needlestick Injuries / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D016273:Occupational Exposure / Q000191:economics / Q000517:prevention & control*; D011482:Protective Devices / Q000191:economics; D012306:Risk
chemical_list: D007328:Insulin